Holen Sie sich die Stockscreener-App
5.86
1.03%
0.06
Vorhandelsmarkt:
5.29
-0.57
-9.73%
Schlusskurs vom Vortag:
$5.80
Offen:
$5.84
24-Stunden-Volumen:
84,924
Relative Volume:
0.30
Marktkapitalisierung:
$6.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.82M
KGV:
-0.00848
EPS:
-691.4213
Netto-Cashflow:
$-8.08M
1W Leistung:
-1.63%
1M Leistung:
+6.16%
6M Leistung:
+67.91%
1J Leistung:
+18.15%
1-Tages-Spanne:
$5.17
$6.00
1-Wochen-Bereich:
$5.08
$6.10
52-Wochen-Spanne:
$2.90
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Firmenname
Endra Life Sciences Inc
Sektor
Branche
Telefon
734-335-0468
Adresse
3600 GREEN COURT, ANN ARBOR, MI
Vergleichen Sie NDRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
5.86 | 6.77M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
573.81 | 211.55B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.42 | 157.68B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.83 | 55.82B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
143.47 | 39.81B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.92 | 37.14B | 15.90B | 1.28B | 2.21B | 7.2842 |
Endra Life Sciences Inc Aktie (NDRA) Neueste Nachrichten
A Look at ENDRA Life Sciences Inc (NDRA) Shares in the Recent Past Indicates Growth - Setenews
ENDRA Life Sciences (NASDAQ:NDRA) Price Target Lowered to $30.00 at Ascendiant Capital Markets - Defense World
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS Registered - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active - Markets Financial Content
Ascendiant Capital Maintains ENDRA Life Sciences (NDRA) Buy Recommendation - Nasdaq
ENDRA Life Sciences (NDRA) Receives Adjusted Price Target with B - GuruFocus
ENDRA’s liver fat measurement device shows high accuracy at key thresholds - Investing.com Nigeria
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
ENDRA Life Sciences (NDRA) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat
Endra Life Sciences (NDRA) Announces Promising Results from Live - GuruFocus
ENDRA Life Sciences stock falls after liver device study results By Investing.com - Investing.com Canada
Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use - Business Wire
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS® Liver Imaging Platform - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS Registered Liver Imaging Platform - openPR.com
ENDRA Life Sciences Inc. (NDRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Jobs Data: What technical charts say about ENDRA Life Sciences Inc. stock2025 Short Interest & Step-by-Step Swing Trade Plans - BỘ NỘI VỤ
ENDRA Life Sciences Announces Management Changes - TradingView
ENDRA Life Sciences Inc. Announces Resignation of Michael Thornton as Chief Technology Officer, Effective November 28, 2025 - marketscreener.com
What analysts say about ENDRA Life Sciences Inc stockBlue Chip Stock Analysis & Free Trading Psychology Coaching - earlytimes.in
You might want to take a look at ENDRA Life Sciences Inc (NDRA) now - Setenews
Can ENDRA Life Sciences Inc. stock attract ESG capital inflowsEarnings Overview Summary & Accurate Buy Signal Alerts - BỘ NỘI VỤ
NDRA registers 2.68M-share resale, pivots to HYPE crypto strategy - Stock Titan
Form DEF 14AOther definitive proxy statements - ADVFN
Form 8-KCurrent report - ADVFN
ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - Markets Financial Content
ENDRA Life Sciences (NASDAQ: NDRA) Advances - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances “Yield-to-Innovation” Strategy to Accelerate Breakthrough Liver Imaging Technology - Barchart.com
ENDRA Life Sciences (NASDAQ:NDRA) Rating Increased to Sell at Wall Street Zen - Defense World
How Market Conditions Affect Cigniti Technologies Limiteds Growth StrategyHigh Beta Stocks & Double Digit Capital Growth - earlytimes.in
How strong is ENDRA Life Sciences Inc. stock revenue growth2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker - BioSpace
ENDRA’s liver fat measurement device shows strong correlation with MRI By Investing.com - Investing.com Nigeria
ENDRA Life Sciences Inc. (NDRA) -21.7% in Normal Trading: Significant Drop Amid Recent Study Announcement - Stocks Telegraph
ENDRA’s liver fat measurement device shows strong correlation with MRI - Investing.com
How ENDRA Life Sciences Inc. stock performs during Fed tightening cyclesJuly 2025 Fed Impact & Daily Market Momentum Tracking - newser.com
Can ENDRA Life Sciences Inc. rally from current levels2025 Bull vs Bear & Technical Pattern Based Buy Signals - newser.com
What dividend safety score for ENDRA Life Sciences Inc. stock2025 Investor Takeaways & Consistent Growth Stock Picks - newser.com
ENDRA Life Sciences Inc. stock daily chart insights2025 Winners & Losers & Technical Pattern Based Buy Signals - newser.com
Why ENDRA Life Sciences Inc. stock remains resilientJuly 2025 Gainers & Weekly Sector Rotation Insights - newser.com
When is the best time to exit ENDRA Life Sciences Inc.Market Volume Summary & Fast Exit and Entry Strategy Plans - newser.com
How institutional ownership impacts ENDRA Life Sciences Inc. stockJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Combining machine learning predictions for ENDRA Life Sciences Inc.2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Editor: 【Market Analysis】 - newser.com
The New Era of Treasury Strategy: ENDRA Life Sciences (NASDAQ: NDRA) Impacting Healthcare - Barchart.com
Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.10%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):